Posted by Michael Wonder on 05 Mar 2020
Life-extending breast cancer drug Ibrance to be fully funded from April
5 March 2020 - Wiki Mulholland, who has advanced breast cancer, and her husband Malcolm have long been campaigning to get PHARMAC to fund a wider range of drugs for cancer. They were 'rapt' to hear Ibrance would be funded from April.
A life-prolonging drug is being fully funded for New Zealanders with advanced (metastatic) breast cancer, saving patients thousands of dollars and ultimately giving them more time.
On Thursday, PHARMAC announced it was funding Ibrance (palbociclib) from April 1. Until now, many of those living with advanced breast cancer had to pay about $6,000 for a month's supply of the drug.
